Last reviewed · How we verify

TRC150094 — Competitive Intelligence Brief

TRC150094 (TRC150094) competitive landscape: 2 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: PPARδ agonist. Area: Metabolic/Endocrinology.

phase 3 PPARδ agonist PPARδ (Peroxisome proliferator-activated receptor delta) Metabolic/Endocrinology Small molecule Live · refreshed every 30 min

Target snapshot

TRC150094 (TRC150094) — Torrent Pharmaceuticals Limited. TRC150094 is a selective peroxisome proliferator-activated receptor delta (PPARδ) agonist that enhances insulin sensitivity and lipid metabolism.

Comparator set (2 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
TRC150094 TARGET TRC150094 Torrent Pharmaceuticals Limited phase 3 PPARδ agonist PPARδ (Peroxisome proliferator-activated receptor delta)
DA-6034 DA-6034 Dong-A ST Co., Ltd. phase 3 PPARδ agonist PPARδ (peroxisome proliferator-activated receptor delta)
ABT-335 ABT-335 AstraZeneca phase 3 PPARδ agonist PPARδ (peroxisome proliferator-activated receptor delta)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (PPARδ agonist class)

  1. AstraZeneca · 1 drug in this class
  2. Dong-A ST Co., Ltd. · 1 drug in this class
  3. Torrent Pharmaceuticals Limited · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). TRC150094 — Competitive Intelligence Brief. https://druglandscape.com/ci/trc150094. Accessed 2026-05-13.

Build your own brief

Pick any drug + add comparators: